Literature DB >> 23178290

The endocannabinoid pathway and the female reproductive organs.

Anna Maria Di Blasio1, Michele Vignali, Davide Gentilini.   

Abstract

Endocannabinoids are endogenous ligands of cannabinoid, vanilloid and peroxisome proliferator-activated receptors that activate multiple signal transduction pathways. Together with their receptor and the enzymes responsible for their synthesis and degradation, these compounds constitute the endocannabinoid system that has been recently shown to play, in humans, an important role in modulating several central and peripheral functions including reproduction. Given the relevance of the system, drugs that are able to interfere with the activity of endocannabinoids are currently considered as candidates for the treatment of various diseases. In this review, we will summarise the current knowledge regarding the effects of endocannabinoids in female reproductive organs. In particular, we will focus on some newly reported mechanisms that can affect endometrial plasticity both in physiological and in pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23178290     DOI: 10.1530/JME-12-0182

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  8 in total

1.  Gene expression of the endocannabinoid system in endometrium through menstrual cycle.

Authors:  Keisuke Tanaka; Akwasi A Amoako; Sally Mortlock; Peter A W Rogers; Sarah J Holdsworth-Carson; Jacqueline F Donoghue; Wan Tinn Teh; Grant W Montgomery; Brett McKinnon
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

2.  Endocannabinoid regulation in human endometrium across the menstrual cycle.

Authors:  Jessica G Scotchie; Ricardo F Savaris; Caitlin E Martin; Steven L Young
Journal:  Reprod Sci       Date:  2014-05-12       Impact factor: 3.060

3.  Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls.

Authors:  Justyna Kuliczkowska Plaksej; Lukasz Laczmanski; Andrzej Milewicz; A Lenarcik-Kabza; Anna Trzmiel-Bira; Urszula Zaleska-Dorobisz; Felicja Lwow; Lidia Hirnle
Journal:  Int J Endocrinol       Date:  2014-07-17       Impact factor: 3.257

4.  The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window.

Authors:  Na Cui; Changyan Wang; Zhiming Zhao; Jie Zhang; Yueming Xu; Yang Yang; Guimin Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-16       Impact factor: 5.555

5.  New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System.

Authors:  Thangesweran Ayakannu; Anthony H Taylor; Timothy H Marczylo; Justin C Konje
Journal:  Med Sci Monit Basic Res       Date:  2019-03-07

6.  Effects of Delta-9 Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development.

Authors:  Megan J Misner; Afton Taborek; Jaustin Dufour; Lea Sharifi; Jibran Y Khokhar; Laura A Favetta
Journal:  Front Toxicol       Date:  2021-03-23

Review 7.  Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications.

Authors:  Harshavardhan Lingegowda; Bailey J Williams; Katherine G Spiess; Danielle J Sisnett; Alan E Lomax; Madhuri Koti; Chandrakant Tayade
Journal:  J Cannabis Res       Date:  2022-10-07

8.  Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis.

Authors:  Xue Shen; Hua Duan; Sha Wang; Lu Gan; Qian Xu; Jin-Jiao Li
Journal:  Biomed Res Int       Date:  2019-01-20       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.